Zdrowie i gospodarka · 29/08/2007

FDA Releases Draft Guidance on Pharmacogenomic Data Submissions

The FDA has released a draft guidance titled "Pharmacogenomic Data Submissions--Companion Guidance" to aid in the use of pharmacogenomic data in drug development, following experience with voluntary genomic data submissions and FDA review of INDs, NDAs, and BLAs since 2005.